Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Antimicrobial Activity of Substituted Benzopentathiepin-6-amines.

Khomenko TM, Korchagina DV, Baev DS, Vassiliev PM, Volcho KP, Salakhutdinov NF.

J Antibiot (Tokyo). 2019 Aug;72(8):590-599. doi: 10.1038/s41429-019-0191-y. Epub 2019 May 22.

PMID:
31118480
2.

Novel Inhibitors of DNA Repair Enzyme TDP1 Combining Monoterpenoid and Adamantane Fragments.

Mozhaitsev ES, Zakharenko AL, Suslov EV, Korchagina DV, Zakharova OD, Vasil'eva IA, Chepanova AA, Black E, Patel J, Chand R, Reynisson J, Leung IKH, Volcho KP, Salakhutdinov NF, Lavrik OI.

Anticancer Agents Med Chem. 2019;19(4):463-472. doi: 10.2174/1871520619666181207094243.

PMID:
30523770
3.

A Novel Class of Tyrosyl-DNA Phosphodiesterase 1 Inhibitors That Contains the Octahydro-2H-chromen-4-ol Scaffold.

Li-Zhulanov NS, Zakharenko AL, Chepanova AA, Patel J, Zafar A, Volcho KP, Salakhutdinov NF, Reynisson J, Leung IKH, Lavrik OI.

Molecules. 2018 Sep 26;23(10). pii: E2468. doi: 10.3390/molecules23102468.

4.

Neuroregeneration in Parkinson's Disease: From Proteins to Small Molecules.

Sidorova YA, Volcho KP, Salakhutdinov NF.

Curr Neuropharmacol. 2019;17(3):268-287. doi: 10.2174/1570159X16666180905094123. Review.

PMID:
30182859
5.

Highly potent activity of isopulegol-derived substituted octahydro-2H-chromen-4-ols against influenza A and B viruses.

Ilyina IV, Zarubaev VV, Lavrentieva IN, Shtro AA, Esaulkova IL, Korchagina DV, Borisevich SS, Volcho KP, Salakhutdinov NF.

Bioorg Med Chem Lett. 2018 Jun 15;28(11):2061-2067. doi: 10.1016/j.bmcl.2018.04.057. Epub 2018 Apr 24.

PMID:
29716780
6.

Novel Semisynthetic Derivatives of Bile Acids as Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibitors.

Salomatina OV, Popadyuk II, Zakharenko AL, Zakharova OD, Fadeev DS, Komarova NI, Reynisson J, Arabshahi HJ, Chand R, Volcho KP, Salakhutdinov NF, Lavrik OI.

Molecules. 2018 Mar 17;23(3). pii: E679. doi: 10.3390/molecules23030679.

7.

Aminoadamantanes containing monoterpene-derived fragments as potent tyrosyl-DNA phosphodiesterase 1 inhibitors.

Ponomarev KY, Suslov EV, Zakharenko AL, Zakharova OD, Rogachev AD, Korchagina DV, Zafar A, Reynisson J, Nefedov AA, Volcho KP, Salakhutdinov NF, Lavrik OI.

Bioorg Chem. 2018 Feb;76:392-399. doi: 10.1016/j.bioorg.2017.12.005. Epub 2017 Dec 9.

PMID:
29248742
8.

Anti-influenza activity of monoterpene-containing substituted coumarins.

Khomenko TM, Zarubaev VV, Orshanskaya IR, Kadyrova RA, Sannikova VA, Korchagina DV, Volcho KP, Salakhutdinov NF.

Bioorg Med Chem Lett. 2017 Jul 1;27(13):2920-2925. doi: 10.1016/j.bmcl.2017.04.091. Epub 2017 Apr 29.

PMID:
28501512
9.

Application of Monoterpenoids and their Derivatives for Treatment of Neurodegenerative Disorders.

Volcho KP, Laev SS, Ashraf GM, Aliev G, Salakhutdinov NF.

Curr Med Chem. 2018;25(39):5327-5346. doi: 10.2174/0929867324666170112101837. Review.

PMID:
28079000
10.

Anti-influenza activity of monoterpene-derived substituted hexahydro-2H-chromenes.

Patrusheva OS, Zarubaev VV, Shtro AA, Orshanskaya YR, Boldyrev SA, Ilyina IV, Kurbakova SY, Korchagina DV, Volcho KP, Salakhutdinov NF.

Bioorg Med Chem. 2016 Nov 1;24(21):5158-5161. doi: 10.1016/j.bmc.2016.08.037. Epub 2016 Aug 22.

PMID:
27591012
11.

A practical way to synthesize chiral fluoro-containing polyhydro-2H-chromenes from monoterpenoids.

Mikhalchenko OS, Korchagina DV, Volcho KP, Salakhutdinov NF.

Beilstein J Org Chem. 2016 Apr 6;12:648-53. doi: 10.3762/bjoc.12.64. eCollection 2016.

12.

Compounds Combining Aminoadamantane and Monoterpene Moieties: Cytotoxicity and Mutagenic Effects.

Suslov EV, Ponomarev KY, Rogachev AD, Pokrovsky MA, Pokrovsky AG, Pykhtina MB, Beklemishev AB, Korchagina DV, Volcho KP, Salakhutdinov NF.

Med Chem. 2015;11(7):629-35.

PMID:
25981517
13.

The short way to chiral compounds with hexahydrofluoreno[9,1-bc]furan framework: synthesis and cytotoxic activity.

Kurbakova SY, Il'ina IV, Mikhalchenko OS, Pokrovsky MA, Korchagina DV, Volcho KP, Pokrovsky AG, Salakhutdinov NF.

Bioorg Med Chem. 2015 Apr 1;23(7):1472-80. doi: 10.1016/j.bmc.2015.02.013. Epub 2015 Feb 16.

PMID:
25737086
14.

Selective Preparation of trans-Carveol over Ceria Supported Mesoporous Materials MCM-41 and SBA-15.

Stekrova M, Kumar N, Mäki-Arvela P, Ardashov OV, Volcho KP, Salakhutdinov NF, Murzin DY.

Materials (Basel). 2013 May 17;6(5):2103-2118. doi: 10.3390/ma6052103.

15.

Antiparkinsonian activity of some 9-N-, O-, S- and C-derivatives of 3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol.

Ardashov OV, Pavlova AV, Korchagina DV, Volcho KP, Tolstikova TG, Salakhutdinov NF.

Bioorg Med Chem. 2013 Mar 1;21(5):1082-7. doi: 10.1016/j.bmc.2013.01.003. Epub 2013 Jan 11.

PMID:
23375447
16.

3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol: the importance of functional groups for antiparkinsonian activity.

Ardashov OV, Pavlova AV, Korchagina DV, Volcho KP, Tolstikova Ty, Salakhutdinov NF.

Med Chem. 2013 Aug;9(5):731-9.

PMID:
23072553
17.

A new synthetic varacin analogue, 8-(trifluoromethyl)-1,2,3,4,5-benzopentathiepin-6-amine hydrochloride (TC-2153), decreased hereditary catalepsy and increased the BDNF gene expression in the hippocampus in mice.

Kulikov AV, Tikhonova MA, Kulikova EA, Volcho KP, Khomenko TM, Salakhutdinov NF, Popova NK.

Psychopharmacology (Berl). 2012 Jun;221(3):469-78. doi: 10.1007/s00213-011-2594-8. Epub 2011 Nov 30.

PMID:
22127556
18.

Highly potent activity of (1R,2R,6S)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol in animal models of Parkinson's disease.

Ardashov OV, Pavlova AV, Il'ina IV, Morozova EA, Korchagina DV, Karpova EV, Volcho KP, Tolstikova TG, Salakhutdinov NF.

J Med Chem. 2011 Jun 9;54(11):3866-74. doi: 10.1021/jm2001579. Epub 2011 May 13.

PMID:
21534547

Supplemental Content

Loading ...
Support Center